Caladrius Biosciences, Inc.
USD0.43
-0.09 (-16.75%)
CEO
David Mazzo
IPO Date
1995-11-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.65
Prev. Close
$0.51
Day Low
$0.38
Day High
$0.65
Market Cap
$0.00B
Volume
26.95M
| -1.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -43.3% | -38.1% | 0.00 | 8.18 | -1.1 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -81.4% | -74.2% | 0.01 | 11.26 | -0.2 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -29.8% | -28.3% | 0.01 | 21.27 | -1.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -25.1% | -22.6% | 0.02 | 10.08 | -2.7 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -96.6% | -74.0% | 0.05 | 4.35 | -1.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -42.9% | -36.3% | 0.00 | 7.85 | -2.1 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 45.5% | 36.3% | 0.00 | 6.56 | 1.5 |
| 31 Dec 2016 | FY | 11.8% | -92.6% | -668.6% | -63.0% | 1.39 | 1.26 | -0.6 |
| -1.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -24.5% | -19.5% | 0.00 | 4.72 | -1.3 |
| 30 Jun 2025 | Q2 | 100.0% | -6655.7% | -22.2% | -18.5% | 0.00 | 5.77 | -1.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -18.6% | -16.3% | 0.00 | 7.52 | -1.1 |
| 31 Dec 2024 | Q4 | 100.0% | -461.0% | -15.6% | -13.2% | 0.00 | 6.16 | -1.3 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -14.6% | -12.9% | 0.01 | 8.03 | -1.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -13.2% | -11.8% | 0.00 | 9.42 | -1.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -12.6% | -11.2% | 0.00 | 8.92 | -1.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -11.1% | -9.8% | 0.00 | 8.18 | -1.0 |